Zobrazeno 1 - 10
of 409
pro vyhledávání: ''
Autor:
Nirav S, Kapadia, Gabriel A, Brooks, Mary Beth, Landrum, Lauren, Riedel, Pang-Hsiang, Liu, Andrea, Hassol, Amanda S, Tripp, Shalini, Jhatakia, Colleen M, Kummet, Nancy L, Keating
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 114:39-46
Radiation utilization for breast cancer and metastatic bone disease varies in modality, fractionation, and cost, despite evidence demonstrating equal effectiveness and consensus recommendations such as Choosing Wisely that advocate for higher value c
Autor:
Alan Nichol, Elisa K. Chan, Stephen Chia, Caroline Lohrisch, Nafisha Lalani, Lovedeep Gondara, Karen A. Gelmon, Daegan Sit, Eric Tran, Caroline Speers
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 112:861-869
Randomized clinical trials have shown that regional nodal irradiation (RNI) in patients with unselected N1 breast cancer improves breast cancer-specific survival. However, the benefit of RNI in women with biologically low-risk N1 breast cancer is unc
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 112:40-51
The omission of radiation therapy (RT) in older women with stage 1 estrogen-receptor-positive (ER+) breast cancer receiving endocrine therapy (ET) is an acceptable strategy based on randomized trial data. Less is known about the omission of ET with o
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 112:52-55
Autor:
Shalin J. Shah, Emily Grade, Elizabeth S. Bloom, Wendy A. Woodward, Benjamin Smith, Isidora Arzu, Julius K. Weng, Xiudong Lei, Pamela J. Schlembach, Karen E. Hoffman, Gabriel N. Hortobagyi, Michael C. Stauder, Gregory M. Chronowski, Valerie Klairisa Reed, Thomas A. Buchholz, Welela Tereffe, Kelly K. Hunt, Eric A. Strom, George H. Perkins, Simona F. Shaitelman, Tomas Dvorak
Publikováno v:
Int J Radiat Oncol Biol Phys
PURPOSE: There are limited prospective data on predictors of patient-reported outcomes (PROs) after whole-breast irradiation (WBI) plus a boost. We sought to characterize longitudinal PROs and cosmesis in a randomized trial comparing conventionally f
Autor:
Renaud Schiappa, Rabia Boulahssass, Jocelyn Gal, Lucile Montagne, Shakeel Sumodhee, Mathieu Gautier, Jean-Michel Hannoun-Levi, Marie-Eve Chand
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:56-67
Accelerated partial breast irradiation (APBI) represents a validated technique for low-risk breast cancer. Recently, ultra-APBI (uAPBI) using fewer than 5 fractions was described in the literature. We compared clinical outcomes and late toxicity afte
Autor:
Caroline Speers, Alan Nichol, Dylan Narinesingh, Lovedeep Gondara, Francois Germain, Elisa K. Chan, Caroline Lohrisch, Srinivas Raman, Pauline T. Truong, Eric Tran
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 110:1360-1369
Purpose Bolus use during postmastectomy radiation therapy doubles the risk of grade 2 and 3 skin toxicity. Despite its unknown benefit, bolus is often prescribed during postmastectomy radiation therapy for patients without skin involvement. Methods a
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 110:783-791
Purpose Autoimmune connective tissue disease (CTD) has historically represented a relative contraindication to breast conservation (BC) among patients with early-stage breast cancer. Controversy exists regarding the use of hypofractionated radiation
Autor:
Seung Yeun Chung, Jaewon Oh, Kyung Hwan Kim, Chang Ok Suh, Ki Chang Keum, Kyeong Hyeon Chun, Yong Bae Kim, Jee Suk Chang, Jaeyong Shin, Seok Min Kang
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 110:473-481
Purpose This retrospective cohort study aimed to determine whether adjuvant radiation therapy increases the risk of cardiac toxicity in Asian women with breast cancer, with a focus on patient-specific factors. Methods and Materials We evaluated women
Autor:
Chae-Seon Hong, Jee Suk Chang, Jin Sung Kim, Hwa Kyung Byun, Nak Hoon Son, Ye-In Park, Namki Hong, Yong Bae Kim, Jihun Kim, Seo Hee Choi
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 110:462-472
To study the hypothyroidism risk after adjuvant radiation therapy (RT) and the association of different RT targets with hypothyroidism risk.We studied 4073 women treated with adjuvant RT for breast cancer from 2007 to 2016. The primary endpoint was h